On April 25, 2023, NuGen Medical Devices Inc. closed the transaction. In connection with the closing of the transaction, the company paid certain eligible persons a cash commission of CAD 235,192.59 in the aggregate and issued 1,323,157 broker warrants. Each broker warrant entitles the holder thereof to acquire one unit at a price of CAD 0.18 per unit for a period of two years from the date of issuance. The company has raised CAD 14,550.5961 from 1 investor pursuant to exemption provided under Regulation D.

The TSX Venture Exchange has accepted for filing documentation with respect to the transaction. The transaction included participation from 92 placees, 1 existing insider for 188,888 units and 2 pro groups for 66,666 units.